(AOF) – Reckitt Benckiser grabs 0.13% to 6,728 pence. The British consumer group has reached an agreement to sell its E45 brand and associated sub-brands to Karo Pharma for an enterprise value of £ 200 million. For the year ended December 31, 2020, the brands had a combined net income of £ 43million.
If completed, the transaction would constitute a further step in Reckitt’s plan to actively manage its portfolio for higher growth, following the recent divestitures of its IFCN business in China and its Scholl brand, as well as the acquisition by Biofreeze.
–
©
AOF
Legal disclaimer
The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights owned by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial or non-commercial exploitation, creation of hypertext link or reuse in any way whatsoever of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from sources it considers the most reliable. However, subject to gross negligence, OPTION FINANCES SAS and its contributors in no way guarantee the absence of errors and defects, even hidden, nor the exhaustive nature or lack of conformity for any use whatsoever of these data and of OPTION FINANCE. SAS or one of its contributors, and cannot be held responsible for delays or interruptions that could affect access to them. The user of the OPTION FINANCE SAS service will use AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.
–
Receive our latest news
Every morning, the information to remember about financial markets.
